期刊文献+

miR-496过表达抑制结肠癌细胞生长和转移 被引量:3

miR-496 over-expression inhibits growth and metastasis in colon cancer cells
下载PDF
导出
摘要 目的:研究miR-496过表达对结肠癌细胞生长和转移的影响及其分子机制。方法:运用生物信息学软件筛选miR-496靶向相互作用蛋白;real-time PCR和Western blot法测定结肠癌细胞系HT29、HCT116、SW480以及正常结肠上皮细胞NCM460中miR-496、CTNNB1 mRNA和β-catenin蛋白的表达;运用Lipofectamine 2000将miR-496 mimics转染HT29、HCT116和SW480细胞,分别命名为HT29-miR-496 mimics、HCT116-miR-496 mimics和SW480-miR-496 mimics细胞,转染scramble为阴性对照;运用MTT法、乳酸脱氢酶(LDH)试剂盒法、克隆形成实验和Transwell分别测定细胞活力、LDH漏出率、克隆形成能力和转移能力;萤光素酶报告基因实验测定miR-496启动子活性;Western blot法测定β-catenin、真核细胞翻译起始因子4E结合蛋白1(4E-BP1)、p-4E-BP1、低密度脂蛋白受体相关蛋白6(LRP6)、p-LRP6、MMP-7、MMP-9、MMP-13以及TIMP-2的蛋白水平。结果:miR-496与β-catenin内源性相互作用;miR-496在HT29、HCT116和SW480细胞中低表达,而在NCM460高表达;β-catenin在HT29、HCT116和SW480细胞中高表达,而在NCM460低表达;培养24 h、48 h、72 h、96 h的HT29-miR-496 mimics、HCT116-miR-496 mimics和SW480-miR-496 mimics细胞活力、LDH漏出率、克隆形成率和转移的细胞数均显著低于对照组(P<0.05);萤光素酶报告基因实验结果显示转染miR-496 mimics细胞中的miR-496启动子活性明显增加(P<0.05),分别是对照组的1.75倍、2.04倍和1.61倍。Western blot实验结果显示miR-496过表达抑制β-catenin蛋白表达,p-4E-BP1和p-LRP6的蛋白水平降低;siRNA或miR-496过表达介导的β-catenin表达下调能显著抑制MMP-7和MMP-9的表达,促进TIMP-2的表达。结论:miR-496在结肠癌细胞中低表达,在正常结肠上皮细胞中高表达;miR-496过表达抑制结肠癌细胞的生长和转移,其机制是通过抑制Wnt/β-catenin通路进一步抑制MMP-7和MMP-9表达,促进TIMP-2表达,从而抑制结肠癌细胞的恶性表型。 AIM: To investigate the effect of miR-496 overexpression on the growth and metastasis of colon cancer cells and its molecular mechanism .METHODS:The proteins interacting with miR-496 were screened by bioinformatic method.The levels of miR-496, CTNNB1 mRNA and β-catenin protein in colon cancer cell lines , HT29, HCT116 and SW480, and normal colonic epithelial cell line NCM 460 were detected by real-time PCR and Western blot .HT29, HCT116 and SW480 cells were transfected with miR-496 mimics using Lipofectamine 2000 and named as HT29-miR-496 mimics, HCT116-miR-496 mimics and SW480-miR-496 mimics cells, respectively, and the cells transfected with the scramble served as negative control .The cell viability, lactate dehydrogenase (LDH) leakage, and colony formation and metastatic abilities were determined by MTT assay , LDH assay, colony formation assay and Transwell method , respectively.The promoter activity of miR-496 was measured using luciferase reporter gene assay .The protein levels of β-catenin, eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), p-4E-BP1, low-density lipoprotein receptor-related protein 6(LRP6), p-LRP6, MMP-7, MMP-9, MMP-13 and TIMP-2 were monitored by Western blot.RESULTS:Endogenous miR-406 interacted with β-catenin was found in the colon cancer cells .Low miR-496 expression in the HT29, HCT116 and SW480 cells and high miR-496 expression in NCM460 cells were detected.In contrast, high β-catenin ex-pression was found in the HT29, HCT116 and SW480 cells and low β-catenin expression was observed in the NCM460 cells.Compared with control group , the cell viability, colony formation rate and the number of metastatic cells remarkably decreased in the HT29-miR-496 mimics, HCT116-miR-496 mimics and SW480-miR-496 mimic cells (P〈0.05).The promoter activity of miR-496 was significantly increased in colon cancer cells transfected with miR-496 mimics, and was 1.75, 2.04 and 1.61 times as high as control group .miR-496 over-expression inhibited β-catenin levels, and p-4E-BP1 and p-LRP6 protein levels were also reduced .siRNA-or over-expressed miR-496-mediated β-catenin down-regulation in-hibited MMP-7 and MMP-9 expression , but promoted TIMP-2 expression .CONCLUSION:The expression level of miR-496 in the colon cancer cells is low , but in the normal colonic epithelial cells is high .miR-496 over-expression inhibits the protein levels of MMP-7 and MMP-9, and promotes the protein expression of TIMP-2 via inhibiting Wnt/β-catenin pathway, thus suppressing malignant phenotype in the colon cancer cells .
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2016年第10期1815-1823,共9页 Chinese Journal of Pathophysiology
关键词 结肠癌 miR-496 WNT/Β-CATENIN 细胞活力 Colon cancer miR-196 Wnt/β-catenin Cell viability
  • 相关文献

参考文献4

二级参考文献19

  • 1朱陵君,陈志鹏,王美林,陈涛,束永前.结直肠癌中miRNA基因及其靶基因多态性位点的研究进展[J].肿瘤防治研究,2014,41(1):69-73. 被引量:7
  • 2Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
  • 3Ciesielska U, Nowinska K, Podhorska-Okolow M, et al. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus[J]. Adv Clin Exp Med, 2012, 21(2):235-244.
  • 4Ju J, Jiang J, Fesler A. miRNA: the new frontier in cancer medicine[J]. Future Med Chem, 2013, 5(9):983-985.
  • 5Chen J, Feflouer HE, Pare GC, et al. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanonla[J]. Am J Pathol, 2010, 176(5):2520-2529.
  • 6Lenarduzzi M, Hui AB, Alajez NM, et al. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1[J]. PLoS One, 2013, 8(1):e53765.
  • 7Bonnet M, Loosveld M, Montpellier B, et al. Posttrans-criptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia[J]. Blood, 2011, 117(24):6650-6659.
  • 8Lee JT, Steelman IS, McCubrey JA. Phosphatidylinositol 3-kinase activation leads to muhidrug resistance protein-1 expression and subsequent chemoresistanee in advanced prostate cancer cells[J]. Cancer Res, 2004, 64(22):8397-8404.
  • 9夏忠胜,朱兆华,陈其奎,钟荚强,张立勇,刘仲敏,ADAM Bao-ling.靶向MDR1基因的RNAi稳定逆转结肠癌细胞的多药耐药性[J].中国病理生理杂志,2009,25(5):898-903. 被引量:13
  • 10郑荣寿,张思维,吴良有,李光琳,赵平,赫捷,陈万青.中国肿瘤登记地区2008年恶性肿瘤发病和死亡分析[J].中国肿瘤,2012,21(1):1-12. 被引量:558

共引文献20

同被引文献22

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部